Cargando…
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo
Glioblastoma (GBM) is the most common and deadly adult brain tumor. Despite aggressive surgery, radiation, and chemotherapy, the life expectancy of patients diagnosed with GBM is ∼14 months. The extremely aggressive nature of GBM results from glioblastoma stem-like cells (GSCs) that sustain GBM grow...
Autores principales: | Signore, M, Pelacchi, F, di Martino, S, Runci, D, Biffoni, M, Giannetti, S, Morgante, L, De Majo, M, Petricoin, E F, Stancato, L, Larocca, L M, De Maria, R, Pallini, R, Ricci-Vitiani, L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047898/ https://www.ncbi.nlm.nih.gov/pubmed/24810059 http://dx.doi.org/10.1038/cddis.2014.188 |
Ejemplares similares
-
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide
por: Tentori, Lucio, et al.
Publicado: (2014) -
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal
por: Lulli, Valentina, et al.
Publicado: (2015) -
Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
por: Falchetti, Maria Laura, et al.
Publicado: (2018) -
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
por: Marziali, G., et al.
Publicado: (2016) -
Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
por: Bartucci, M, et al.
Publicado: (2012)